Covered recipient · General Payments record
JONATHAN CHAPEKIS
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2021–2024
$2,776.30
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,053.71 | 16 |
| Travel and Lodging | $533.22 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $638.46 | 5 |
| Medtronic, Inc. | $380.67 | 6 |
| BOSTON SCIENTIFIC CORPORATION | $328.74 | 2 |
| MML US, Inc. | $86.76 | 1 |
| Saluda Medical Americas, Inc. | $82.54 | 1 |
| Vertos Medical, Inc. | $35.12 | 1 |
| FORTE BIO-PHARMA LLC | $34.64 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation | $167.28 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092385422 | CMS |
| Boston Scientific Corporation | $161.46 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092385420 | CMS |
| Forte Bio-Pharma LLC | $18.28 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142416295 | CMS |
| Forte Bio-Pharma LLC | $16.36 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142416297 | CMS |
| Medtronic, Inc. | $12.95 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167380 | CMS |
| Medtronic, Inc. | $150.28 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167384 | CMS |
| Medtronic, Inc. | $20.98 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167393 | CMS |
| Medtronic, Inc. | $28.66 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167398 | CMS |
| Medtronic, Inc. | $140.67 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167402 | CMS |
| Medtronic, Inc. | $27.13 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167406 | CMS |
| MML US, Inc. | $86.76 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152306291 | CMS |
| Nevro Corp. | $365.94 | 08/02/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130771598 | CMS |
| Nevro Corp. | $149.58 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130771610 | CMS |
| Nevro Corp. | $33.71 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130771594 | CMS |
| Nevro Corp. | $66.87 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130771596 | CMS |
| Nevro Corp. | $22.36 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130771604 | CMS |
| Saluda Medical Americas, Inc. | $82.54 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081870880 | CMS |
| Vertos Medical, Inc. | $35.12 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133343115 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.